Position in HIMS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$108,799,337
-$502,879,285 QoQ
Shares Held
5,240,816
-72.2% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 90.50987479812304.ToString("F0")%
Shared 0.0038161996147164866.ToString("F0")%
None 9.486309002262242.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,049 across 61 Drug Manufacturers - Specialty & Generic names. HIMS ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
This page
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in HIMS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,799,337 | 5,240,816 | Shares | Other | 2026-05-13 | |
| 2026-02-27 | $56,363,590 | 3,881,790 | Shares | Sole | 2026-03-05 | |
| 2025-12-31 | $611,678,622 | 18,838,270 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,008,826,736 | 17,786,085 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $136,607,690 | 2,740,375 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $77,680,445 | 2,628,780 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $65,528,137 | 2,710,014 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $37,763,245 | 2,050,122 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $51,568,609 | 2,554,166 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $4,892,402 | 316,251 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,486,299 | 167,000 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,047,598 | 166,550 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,670,219 | 177,683 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,489,011 | 351,715 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $804,383 | 125,489 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $626,148 | 112,213 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $509,914 | 112,564 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $188,324 | 35,333 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $615,305 | 93,940 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $734,592 | 97,426 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $168,141 | 15,440 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||